Jiutian Chemical (SGX:C8R) reported a full-year loss of 147.9 million yuan for fiscal year 2024, 97,000 yuan more than previously stated, after audit adjustments, according to a Monday filing on the Singapore Exchange.
Revenue was restated to 50.6 million yuan from 243.8 million yuan after reclassifying certain trades as agency transactions. Cost of sales dropped in line, leaving gross profit unchanged.
Finance costs rose to 6.1 million yuan after correcting the capitalization of borrowing costs. Other changes included asset reclassifications, tax provisions, and the reversal of excess impairment losses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.